Therapeutic effect of hepatocyte growth factor-secreting mesenchymal stem cells in a rat model of liver fibrosis

Experimental and Molecular Medicine

Volumn 46, Issue 8, 2014, Pages

  Kim, Myung Deok ^a   Kim, Sung Soo ^a   Cha, Hyun Young ^a   Jang, Seung Hun ^a   Chang, Da Young ^a   Kim, Wookhwan ^a   Suh Kim, Haeyoung ^a   Lee, Jae Ho ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; COLLAGEN; COLLAGENASE 3; COMPLEMENTARY DNA; GELATINASE B; MATRIX METALLOPROTEINASE 14; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR BB; SCATTER FACTOR; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA1; UROKINASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CELL FUNCTION; CELL THERAPY; CONTROLLED STUDY; GENE OVEREXPRESSION; GENETIC ENGINEERING; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; INJECTION; LIVER CELL; LIVER FIBROSIS; LIVER FUNCTION; LIVER HISTOLOGY; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; PORTAL VEIN; PROTEIN EXPRESSION; RAT MODEL; SPLEEN; THERAPY EFFECT; ANIMAL; CELL CULTURE; CELL ENGINEERING; GENETICS; LIVER; LIVER CIRRHOSIS; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY; RAT; SPRAGUE DAWLEY RAT; UPREGULATION;

ANIMALS; CELL ENGINEERING; CELLS, CULTURED; GENETIC ENGINEERING; HEPATOCYTE GROWTH FACTOR; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; RATS; RATS, SPRAGUE-DAWLEY; UP-REGULATION;

EID: 84906855894     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.1038/emm.2014.49     Document Type: Article

References (39)

1. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest 2005; 115: 209-218.
2. Sakaida I, Terai S, Yamamoto N, Aoyama K, Ishikawa T, Nishina H et al. Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice. Hepatology 2004; 40: 1304-1311.
3. Fang B, Shi M, Liao L, Yang S, Liu Y, Zhao RC. Systemic infusion of FLK1() mesenchymal stem cells ameliorate carbon tetrachlorideinduced liver fibrosis in mice. Transplantation 2004; 78: 83-88.
4. Oyagi S, Hirose M, Kojima M, Okuyama M, Kawase M, Nakamura T et al. Therapeutic effect of transplanting HGF-treated bone marrow mesenchymal cells into CCl4-injured rats. J Hepatol 2006; 44: 742-748.
5. Ong SY, Dai H, Leong KW. Hepatic differentiation potential of commercially available human mesenchymal stem cells. Tissue Eng 2006; 12: 3477-3485.
6. Lee KD, Kuo TK, Whang-Peng J, Chung YF, Lin CT, Chou SH et al. In vitro hepatic differentiation of human mesenchymal stem cells. Hepatology 2004; 40: 1275-1284.
7. Ong SY, Dai H, Leong KW. Inducing hepatic differentiation of human mesenchymal stem cells in pellet culture. Biomaterials 2006; 27: 4087-4097.
8. Zhan Y, Wang Y, Wei L, Chen H, Cong X, Fei R et al. Differentiation of hematopoietic stem cells into hepatocytes in liver fibrosis in rats. Transplant Proc 2006; 38: 3082-3085.
9. Carvalho AB, Quintanilha LF, Dias JV, Paredes BD, Mannheimer EG, Carvalho FG et al. Bone marrow multipotent mesenchymal stromal cells do not reduce fibrosis or improve function in a rat model of severe chronic liver injury. Stem Cells 2008; 26: 1307-1314.
10. Kallis YN, Alison MR, Forbes SJ. Bone marrow stem cells and liver disease. Gut 2007; 56: 716-724.
11. Russo FP, Alison MR, Bigger BW, Amofah E, Florou A, Amin F et al. The bone marrow functionally contributes to liver fibrosis. Gastroenterology 2006; 130: 1807-1821.
12. Forbes SJ, Russo FP, Rey V, Burra P, Rugge M, Wright NA et al. A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis. Gastroenterology 2004; 126: 955-963.
13. di Bonzo LV, Ferrero I, Cravanzola C, Mareschi K, Rustichell D, Novo E et al. Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: engraftment and hepatocyte differentiation versus profibrogenic potential. Gut 2008; 57: 223-231.
14. Parekkadan B, van Poll D, Megeed Z, Kobayashi N, Tilles AW, Berthiaume F et al. Immunomodulation of activated hepatic stellate cells by mesenchymal stem cells. Biochem Biophys Res Commun 2007; 363: 247-252.
15. Mizuno S, Nakamura T. Hepatocyte growth factor: A regenerative drug for acute hepatitis and liver cirrhosis. Regen Med 2007; 2: 161-170.
16. Matsuno Y, Iwata H, Umeda Y, Takagi H, Mori Y, Kosugi A et al. Hepatocyte growth factor gene transfer into the liver via the portal vein using electroporation attenuates rat liver cirrhosis. Gene Ther 2003; 10: 1559-1566.
17. Ueki T, Kaneda Y, Tsutsui H, Nakanishi K, Sawa Y, Morishita R et al. Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nat Med 1999; 5: 226-230.
18. Matsuda Y, Matsumoto K, Yamada A, Ichida T, Asakura H, Komoriya Y et al. Preventive and therapeutic effects in rats of hepatocyte growth factor infusion on liver fibrosis/cirrhosis. Hepatology 1997; 26: 81-89.
19. Yasuda H, Imai E, Shiota A, Fujise N, Morinaga T, Higashio K. Antifibrogenic effect of a deletion variant of hepatocyte growth factor on liver fibrosis in rats. Hepatology 1996; 24: 636-642.
20. Kim WH, Matsumoto K, Bessho K, Nakamura T. Growth inhibition and apoptosis in liver myofibroblasts promoted by hepatocyte growth factor leads to resolution from liver cirrhosis. Am J Pathol 2005; 166: 1017-1028.
21. Ishii T, Sato M, Sudo K, Suzuki M, Nakai H, Hishida T et al. Hepatocyte growth factor stimulates liver regeneration and elevates blood protein level in normal and partially hepatectomized rats. J Biochem (Tokyo) 1995; 117: 1105-1112.
22. Kim SS, Yoo SW, Park TS, Ahn SC, Jeong HS, Kim JW et al. Neural induction with neurogenin1 increases the therapeutic effects of mesenchymal stem cells in the ischemic brain. Stem Cells 2008; 26: 2217-2228.
23. Edwards CA, O'Brien Jr. WD. Modified assay for determination of hydroxyproline in a tissue hydrolyzate. Clin Chim Acta 1980; 104: 161-167.
24. Balkovetz DF. Hepatocyte growth factor and Madin-Darby canine kidney cells: in vitro models of epithelial cell movement and morphogenesis. Microsc Res Tech 1998; 43: 456-463.
25. Tsukamoto H, Matsuoka M, French SW. Experimental models of hepatic fibrosis: A review. Semin Liver Dis 1990; 10: 56-65.
26. Udenfriend S. Formation of hydroxyproline in collagen. Science 1966; 152: 1335-1340.
27. Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 2000; 275: 2247-2250.
28. Arthur MJ., Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis. Am J Physiol Gastrointest Liver Physiol 2000; 279: G245-G249.
29. Grigorescu M. Noninvasive biochemical markers of liver fibrosis. J Gastrointest Liver Dis 2006; 15: 149-159.
30. Okazaki I, Watanabe T, Hozawa S, Niioka M, Arai M, Maruyama K. Reversibility of hepatic fibrosis: from the first report of collagenase in the liver to the possibility of gene therapy for recovery. Keio J Med 2001; 50: 58-65.
31. Asawa S, Saito T, Satoh A, Ohtake K, Tsuchiya T, Okada H et al. Participation of bone marrow cells in biliary fibrosis after bile duct ligation. J Gastroenterol Hepatol 2007; 22: 2001-2008.
32. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005; 105: 1815-1822.
33. Inoue S, Popp FC, Koehl GE, Piso P, Schlitt HJ, Geissler EK et al. Immunomodulatory effects of mesenchymal stem cells in a rat organ transplant model. Transplantation 2006; 81: 1589-1595.
34. Sotiropoulou PA, Perez SA, Gritzapis AD, Baxevanis CN, Papamichail M. Interactions between human mesenchymal stem cells and natural killer cells. Stem Cells 2006; 24: 74-85.
35. Futamatsu H, Suzuki J, Mizuno S, Koga N, Adachi S, Kosuge H et al. Hepatocyte growth factor ameliorates the progression of experimental autoimmune myocarditis: A potential role for induction of T helper 2 cytokines. Circ Res 2005; 96: 823-830.
36. Okunishi K, Dohi M, Nakagome K, Tanaka R, Mizuno S, Matsumoto K et al. A novel role of hepatocyte growth factor as an immune regulator through suppressing dendritic cell function. J Immunol 2005; 175: 4745-4753.
37. Ito W, Kanehiro A, Matsumoto K, Hirano A, Ono K, Maruyama H et al. Hepatocyte growth factor attenuates airway hyperresponsiveness, inflammation, and remodeling. Am J Respir Cell Mol Biol 2005; 32: 268-280.
38. Yamaura K, Ito K, Tsukioka K, Wada Y, Makiuchi A, Sakaguchi M et al. Suppression of acute and chronic rejection by hepatocyte growth factor in a murine model of cardiac transplantation: induction of tolerance and prevention of cardiac allograft vasculopathy. Circulation 2004; 110: 1650-1657.
39. Madden JW, Gertman PM, Peacock Jr EE. Dimethylnitrosamine-induced hepatic cirrhosis: A new canine model of an ancient human disease. Surgery 1970; 68: 260-267; discussion 267-8.